Gregory M. Springett

6.1k citations

86 papers · 4.4k indexed · 1 hit paper · h-index 30

Impact in

Oncology top 1%
- Pancreatic and Hepatic Oncology Research
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Oncology 64
- Pancreatic and Hepatic Oncology Research 51
- Cancer Diagnosis and Treatment 6
Cancer Research 26
- Cancer Genomics and Diagnostics 24

Co-authors: David E. Housman Ann M. Graybiel Michiyuki Matsuda Shinichiro Toki Hiroaki Kawasaki Naoki Mochizuki Mie Nakaya Sarah E. Hoffe
Journals: Journal of Clinical Oncology (25 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Clinical Cancer Research (3 papers)Cancer Control (3 papers)Cancer Research (2 papers)
Partner nations: United States Japan Canada

In The Last Decade

Gregory M. Springett

84 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

A Family of cAMP-Binding Proteins That Directly Activate Rap1 1998 · 1.2k citations

Peers

Countries citing papers authored by Gregory M. Springett

Since Specialization

Citations

This map shows the geographic impact of Gregory M. Springett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Springett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Springett more than expected).

Fields of papers citing papers by Gregory M. Springett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Springett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Springett. The network helps show where Gregory M. Springett may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gregory M. Springett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory M. Springett Line = papers co-authored together Gregory M. Springett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study Journal of Vascular and Interventional Radiology ·Alexandra Gangi, Mahmoud R. Mohammed, Fuxing Tao, Riaz Tejani, Jennifer Sweeney, Junsung Choi, Ghassan El‐Haddad, Kelsey A. Loy, Nainesh Parikh, Bülent Arslan, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Daniel A. Anaya, Mokenge P. Malafa, Dung‐Tsa Chen, Yunyun Chen, Richard D. Kim, Ravi Shridhar, Béla Kis	2018	56
2	Outcomes of adjuvant radiotherapy and lymph node resection in elderly patients with pancreatic cancer treated with surgery and chemotherapy Journal of Gastrointestinal Oncology ·Jessica M. Frakes, Eric A. Mellon, Gregory M. Springett, Pamela J. Hodul, Mokenge P. Malafa, William J. Fulp, Xiuhua Zhao, Sarah E. Hoffe, Ravi Shridhar, Kenneth Meredith	2017	12
3	Patterns of recurrence and long-term outcomes in patients who underwent pancreatectomy for intraductal papillary mucinous neoplasms with high grade dysplasia: implications for surveillance and future management guidelines HPB ·Aaron U. Blackham, Matthew P. Doepker, Barbara A. Centeno, Gregory M. Springett, José M. Pimiento, Mokenge P. Malafa, Pamela J. Hodul	2017	14
4	Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers BMJ Open ·Timothy Kubal, Hanzu Lee, Alberto Chiappori, Gregory M. Springett, Riti Shimkhada, Seung Kwi Choi, John Peabody	2016	13
5	Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer Journal of Gastrointestinal Oncology ·Eric A. Mellon, Tobin J. Strom, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Pamela J. Hodul, Mokenge P. Malafa, Michael D. Chuong, Ravi Shridhar	2016	39
6	A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer Journal of Gastrointestinal Cancer ·William B. Street, William J. Fulp, Gregory M. Springett, Sarah E. Hoffe, Amit Mahipal	2015	14
7	Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer Cancer Chemotherapy and Pharmacology ·Никонова Наталья Анатольевна, Amit Mahipal, David Shibata, Erin M. Siegel, Jiahao Xiao, William J. Fulp, Gregory M. Springett, Richard D. Kim	2015	7
8	A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia EBioMedicine ·Gregory M. Springett, Kazim Husain, Anthony Neuger, Barbara A. Centeno, Dung‐Tsa Chen, Dominik Wesche, Richard M. Lush, Saı̈d M. Sebti, Mokenge P. Malafa	2015	65
9	Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer Radiotherapy and Oncology ·T. Ström, Sarah E. Hoffe, William J. Fulp, Jessica M. Frakes, Domenico Coppola, Gregory M. Springett, Mokenge P. Malafa, Cynthia L. Harris, Steven A. Eschrich, Javier F. Torres–Roca, Ravi Shridhar	2015	69
10	Resected pancreatic cancer outcomes in the elderly Journal of Geriatric Oncology ·Jessica M. Frakes, T. Ström, Gregory M. Springett, Sarah E. Hoffe, Lodovico Balducci, Pamela J. Hodul, Mokenge P. Malafa, Ravi Shridhar	2014	32
11	Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma Cancer Immunology Immunotherapy ·Tomar Ghansah, Nasreen A. Vohra, Лернер Евгения Леонидовна, Amy Weber, Krithika N. Kodumudi, Gregory M. Springett, Amod A. Sarnaik, Shari Pilon‐Thomas	2013	54
12	Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated International Journal of Radiation OncologyBiologyPhysics ·Michael D. Chuong, Gregory M. Springett, J. Freilich, Yuki FUKUDA, Jill Weber, Eric A. Mellon, Pamela J. Hodul, Mokenge P. Malafa, Kenneth Meredith, Sarah E. Hoffe, Ravi Shridhar	2013	267
13	Lysophosphatidic Acid Acyltransferase Beta Regulates mTOR Signaling PLoS ONE ·Michelle A. Blaskovich, I. Valin, Harshani R. Lawrence, Nicholas J. Lawrence, Saı̈d M. Sebti, Gregory M. Springett	2013	19
14	Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors Clinical Cancer Research ·Adil Daud, Smitha Krishnamurthi, Mansoor N. Saleh, Barbara J. Gitlitz, Mitesh J. Borad, Philip J. Gold, Elena G. Chiorean, Gregory M. Springett, Richat Abbas, Shefali Agarwal, Nathalie Bardy‐Bouxin, Poe‐Hirr Hsyu, Eric Leip, Kathleen Turnbull, Charles Zacharchuk, Wells A. Messersmith	2011	68
15	Neoadjuvant GTX Chemotherapy and IMRT‐based chemoradiation for borderline resectable pancreatic cancer Journal of Surgical Oncology ·Manish R. Patel, Sarah E. Hoffe, Mokenge P. Malafa, Pamela J. Hodul, Jason Klapman, Barbara A. Centeno, Jongphil Kim, James F. Helm, Tiffany Valone, Gregory M. Springett	2011	78
16	Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population Psychiatric Genetics ·Leo Gotoh, Hiroshi Mitsuyasu, Steven Milewski, Naoya Oribe, Atsushi Takata, Hideaki Ninomiya, Vincent P. Stanton, Gregory M. Springett, Hiroaki Kawasaki, Shigenobu Kanba	2009	19
17	Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker British Journal of Cancer ·Pamela N. Münster, Douglas C. Marchion, Scott Thomas, Merrill J. Egorin, S. Minton, Gregory M. Springett, Ji‐Hyun Lee, George R. Simon, Alberto Chiappori, Dan M. Sullivan, Adil Daud	2009	135
18	Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells Cell Cycle ·Aslamuzzaman Kazi, Harshani R. Lawrence, Wayne C. Guida, Mark L. McLaughlin, Gregory M. Springett, Norbert Berndt, Richard Yip, Saı̈d M. Sebti	2009	39
19	Genetic structure of the dopamine receptor D4 gene (DRD4) and lack of association with schizophrenia in Japanese patients Journal of Psychiatric Research ·Hiroshi Mitsuyasu, Hiroaki Kawasaki, Hideaki Ninomiya, Naoko Kinukawa, Takeharu Yamanaka, Tomoko Tahira, Vincent P. Stanton, Gregory M. Springett, Kenshi Hayashi, Nobutada Tashiro, Shigenobu Kanba	2006	7
20	Non‐kinase second‐messenger signaling: new pathways with new promise BioEssays ·Gregory M. Springett, Hiroaki Kawasaki, David R. Spriggs	2004	61

About Gregory M. Springett

Gregory M. Springett is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Biotechnology and Epidemiology, having authored 86 papers that have together received 4.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (51 papers), Cancer Genomics and Diagnostics (24 papers), Neuroendocrine Tumor Research Advances (19 papers), Pancreatitis Pathology and Treatment (14 papers), Renal cell carcinoma treatment (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Diagnosis and Treatment (6 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (694 citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (836 citations) and Physiology (113 citations). Gregory M. Springett has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include David E. Housman, Ann M. Graybiel, Michiyuki Matsuda, Shinichiro Toki, Hiroaki Kawasaki, Naoki Mochizuki, Mie Nakaya, Sarah E. Hoffe, Mokenge P. Malafa and Pamela J. Hodul. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Cancer Control and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact